The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon
- PMID: 18334285
- DOI: 10.1016/j.mehy.2007.08.032
The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon
Abstract
Hepatitis B virus (HBV) is a small DNA virus that targets the liver almost exclusively. Chronic infection with HBV might lead to severe liver-related pathologies including chronic hepatitis, cirrhosis and hepatocellular carcinoma. Based on its enhancer composition, which links nutritional signals that control hepatic glucose and fat metabolism in the liver to HBV gene expression and replication, it appears that the virus has adopted a regulatory system that is unique to the major hepatic metabolic genes. This unique virus-host interaction, mediated by metabolic events in the liver, is designated by us the "metabolovirus model". We hypothesize that by mimicking the expression of key genes implicated in glucose homeostasis, HBV sophisticatedly exploits the host resources to ensure its persistence. Specifically, by recruiting transcription factors and coactivators common to essential hepatic metabolic genes the virus avoids a possible resistance by its host, on the one hand, and ensures a timely and proper response to changes in its environment in terms of metabolic milieu, on the other hand. Furthermore, by coupling its gene expression to the expression of hepatic metabolic genes that fluctuate during the day, we predict a fluctuating nature of HBV gene expression. This can serve the virus in its attempts to escape the host immune system in addition to other immune evading strategies adopted by the virus, such as the secretion of the e antigen. Based on our "metabolovirus model", we suggest new mechanisms to previously unexplained clinical phenomena, such as the observed diversity in disease severity between different geographical areas that differ in nutritional habits. Furthermore, given the up-regulatory effect of food deprivation on HBV gene expression and replication, we suggest that conditions of short-term starvation should be completely avoided by HBV-infected individuals, and dietary recommendations such as the ingestion of complex carbohydrates before sleep should be adopted. Thus, our hypothesis sets the stage for viral manipulation by controlling food intake, and opens additional avenues towards food or nutritional therapy as an effective anti-HBV weapon.
Similar articles
-
Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression.Liver Int. 2011 Mar;31(3):282-90. doi: 10.1111/j.1478-3231.2010.02423.x. Epub 2011 Jan 11. Liver Int. 2011. PMID: 21281428 Review.
-
Viral determinants and host immune responses in the pathogenesis of HBV infection.J Med Virol. 2002 Jul;67(3):454-7. doi: 10.1002/jmv.10096. J Med Virol. 2002. PMID: 12116045 Review.
-
Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.Gene Ther. 2005 Apr;12(8):668-77. doi: 10.1038/sj.gt.3302449. Gene Ther. 2005. PMID: 15647761
-
Diagnosis of hepatitis B virus infection through serological and virological markers.Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):553-62. doi: 10.1586/17474124.2.4.553. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072403 Review.
-
PGC-1alpha controls hepatitis B virus through nutritional signals.Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16003-8. doi: 10.1073/pnas.0607837103. Epub 2006 Oct 16. Proc Natl Acad Sci U S A. 2006. PMID: 17043229 Free PMC article.
Cited by
-
Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases.Front Microbiol. 2022 Nov 2;13:1039614. doi: 10.3389/fmicb.2022.1039614. eCollection 2022. Front Microbiol. 2022. PMID: 36406414 Free PMC article.
-
GCN5 acetyltransferase inhibits PGC1α-induced hepatitis B virus biosynthesis.Virol Sin. 2013 Aug;28(4):216-22. doi: 10.1007/s12250-013-3344-3. Epub 2013 Jul 2. Virol Sin. 2013. PMID: 23913178 Free PMC article.
-
Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.United European Gastroenterol J. 2018 May;6(4):558-566. doi: 10.1177/2050640617751252. Epub 2018 Jan 16. United European Gastroenterol J. 2018. PMID: 29881611 Free PMC article.
-
Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice.J Virol. 2009 Feb;83(4):1682-8. doi: 10.1128/JVI.02208-08. Epub 2008 Dec 10. J Virol. 2009. PMID: 19073739 Free PMC article.
-
Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.PLoS One. 2017 May 15;12(5):e0177713. doi: 10.1371/journal.pone.0177713. eCollection 2017. PLoS One. 2017. PMID: 28505202 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical